Internal Medicine · Laurelton, NY
NPI
1780632844
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
224-14 Merrick Blvd
Laurelton, NY, 11413
Phone (718) 949-9400
Groups this clinician bills Medicare through
Medicare paid, 2024
$430K
5,592 services
Medicare patients, 2024
331
Average age 74
Drug cost, 2024
$5.0M
7,680 prescriptions
Company payments, 2025
$126K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Olakunle O Akinboboye was code 99213 (office e&m - established), 802 times for 283 patients. In total Olakunle O Akinboboye billed 5,592 services in 49 codes, and Medicare paid $430K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 802 | 283 | $71.67 | $57K |
| 99458 E&M - Miscellaneous | Office | 741 | 75 | $33.99 | $25K |
| 99457 E&M - Miscellaneous | Office | 716 | 86 | $42.58 | $30K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 572 | 91 | $36.94 | $21K |
| 99454 E&M - Miscellaneous | Office | 490 | 68 | $42.33 | $21K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 363 | 72 | $34.64 | $13K |
| 93306 Echocardiography (TTE/TEE) | Office | 240 | 215 | $165.74 | $40K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 208 | 102 | $235.20 | $49K |
| 99214 Office E&M - Established | Office | 189 | 126 | $99.68 | $19K |
| 93000 Electrocardiogram | Office | 159 | 144 | $10.67 | $1,697 |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 134 | 38 | $41.54 | $5,567 |
| 93015 Electrocardiogram | Office | 111 | 108 | $58.12 | $6,451 |
| 78452 Myocardial Perfusion Scan | Office | 108 | 106 | $396.41 | $43K |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 96 | 38 | $85.60 | $8,218 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 80 | 20 | $6.22 | $498 |
By year: 2022 $598K for 7,677 services; 2023 $514K for 6,844 services; 2024 $430K for 5,592 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 34 | 33 | $8.40 | $286 |
Medicare prescription drug claims, 2024
In 2024, the drug Olakunle O Akinboboye prescribed most often to Medicare patients was Amlodipine Besylate, with 548 prescriptions and refills. In total Olakunle O Akinboboye wrote 7,680 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 548 | 1,383 | 172 | $3,002 |
| Atorvastatin Calcium Generic | 484 | 1,219 | 158 | $4,121 |
| Rosuvastatin Calcium Generic | 356 | 910 | 122 | $4,580 |
| Carvedilol Generic | 220 | 440 | 55 | $1,212 |
| Amlodipine Besylate-Benazepril Amlodipine Besylate/Benazepril | 220 | 559 | 63 | $2,940 |
| Ozempic Semaglutide | 208 | 284 | 37 | $254K |
| Metformin Hcl Generic | 207 | 514 | 67 | $1,281 |
| Farxiga Dapagliflozin Propanediol | 185 | 351 | 51 | $192K |
| Metoprolol Succinate Generic | 178 | 478 | 62 | $2,472 |
| Spironolactone Generic | 165 | 344 | 49 | $804 |
| Clonidine Hcl Generic | 147 | 337 | 41 | $749 |
| Entresto Sacubitril/Valsartan | 140 | 257 | 35 | $163K |
| Hydrochlorothiazide Generic | 135 | 332 | 50 | $574 |
| Losartan Potassium Generic | 126 | 303 | 38 | $1,051 |
| Eliquis Apixaban | 115 | 235 | 32 | $133K |
Brand drugs: 1,665 claims; generic drugs: 5,932 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Olakunle O Akinboboye $126K ($126K in general payments such as food, travel and fees) from 24 companies. The largest payer was Alnylam Pharmaceuticals Inc. with $96K.
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. ALNY | 84 | $96K |
| BridgeBio Pharma, Inc. BBIO | 10 | $14K |
| AstraZeneca Pharmaceuticals LP AZN | 29 | $7,602 |
| Pfizer Inc. PFE | 15 | $4,513 |
| Merck Sharp & Dohme LLC MRK | 20 | $2,108 |
| VivaQuant Inc, dba Rhythm Express | 2 | $728 |
| Novo Nordisk Inc NVO | 6 | $218 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $205 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $158 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $153 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.